Funding opportunity – “Bugs as Drugs”

Funding opportunity – “Bugs as Drugs”

The National Cancer Institute’s Division of Cancer Treatment and Diagnosis has a funding opportunity for microbial-based cancer therapy. Microbial-based cancer therapy has the potential as a treatment for conditions where conventional cancer therapies are inadequate. However, despite this potential, the field is not well developed and relatively little research has been done to advance research on novel microbial-based anticancer therapeutic agents by exploring the complexities of microbial-tumor interactions and microbial anti-tumor activation of the immune system.

Learn more here:

https://grants.nih.gov/grants/guide/pa-files/PAR-19-193.html

https://grants.nih.gov/grants/guide/pa-files/PAR-19-194.html

Leave a reply

Your email address will not be published. Required fields are marked *